Craneware plc (LON:CRW) had its target price lifted by Peel Hunt from GBX 1,495 ($19.73) to GBX 1,800 ($23.75) in a research note released on Tuesday morning, Marketbeat Ratings reports. They currently have a buy rating on the stock.
Separately, N+1 Singer reaffirmed a hold rating on shares of Craneware plc in a research note on Tuesday, September 5th.
ILLEGAL ACTIVITY NOTICE: “Peel Hunt Boosts Craneware plc (CRW) Price Target to GBX 1,800” was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.com-unik.info/2017/11/03/peel-hunt-boosts-craneware-plc-crw-price-target-to-gbx-1800.html.
The business also recently disclosed a dividend, which will be paid on Thursday, December 7th. Investors of record on Thursday, November 9th will be paid a dividend of GBX 11.30 ($0.15) per share. The ex-dividend date is Thursday, November 9th. This represents a dividend yield of 0.85%. This is a positive change from Craneware plc’s previous dividend of $8.70.
About Craneware plc
Craneware plc is a United Kingdom-based company, which is engaged in the development, licensing and ongoing support of computer software for the United States healthcare industry. The Company’s Value Cycle Solutions span over five product families, which include Patient Engagement, Charge Capture & Pricing, Coding Integrity, Cost Analytics, and Revenue Collection & Retention.
What are top analysts saying about Craneware plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Craneware plc and related companies.